PHR Form 144 Shows 78-Share Proposed Sale; Prior Insider Sales Listed

Rhea-AI Filing Summary

Form 144 notice for Phreesia, Inc. (PHR) discloses a proposed sale of 78 restricted common shares by an insider through Fidelity Brokerage Services with an aggregate market value of $2,274.13, with an approximate sale date of 08/18/2025 on the NYSE. The shares were acquired on 08/15/2025 via restricted stock vesting and were paid as compensation. The filing also lists prior insider sales in the past three months: Jessica Weiss sold 42 and 67 shares on 06/17/2025 and 06/18/2025 respectively, and David Linetsky sold 23,729 shares on 06/27/2025 and 2,063 shares on 07/17/2025, with gross proceeds shown for each sale. The filer certifies no undisclosed material adverse information and includes the statutory warning about intentional misstatements.

Positive

• Transaction transparency: Filing provides clear details on acquisition date, nature (restricted stock vesting), payment method (compensation), and proposed sale date.
• Insider compliance: Multiple insiders reported recent sales, indicating adherence to Rule 144 reporting requirements.

Negative

• Insider sales magnitude: Recent sale of 23,729 shares by David Linetsky with gross proceeds of $676,195.48 is the largest disclosed transaction, which investors may view as notable even though the filing lacks context on post-sale holdings.
• Limited context: Filing does not disclose percentage ownership, reasons for sales beyond vesting, or whether trades are pursuant to a 10b5-1 plan.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing a small compensation-related sale and recent insider dispositions; no new operational or financial data.

The filing reports a proposed sale of 78 restricted shares acquired through vesting and paid as compensation, alongside several recent insider sales totaling 25,901 shares over June–July 2025 with stated gross proceeds. These disclosures are transactional and comply with Rule 144 reporting requirements; they do not include earnings, financial condition, or forward-looking operational items. The largest reported sale (23,729 shares) generated roughly $676,195 per the filing, but the form does not state context such as percentage ownership or holdings post-sale, limiting assessment of insider intent or impact on capitalization.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; confirms insiders are executing reported sales including vested compensation.

The notice documents a compensation-related vesting event followed by a proposed Rule 144 sale and lists earlier dispositions by named insiders. The signer affirms absence of undisclosed material adverse information, which is standard. The filing does not present governance changes, trading plans, or indications of Rule 10b5-1 adoption, and contains no dates or details about any trading plans. From a governance perspective, this is a routine insider reporting filing rather than a material corporate development.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	78	2274.13	59504269	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock Vesting	Issuer			78	08/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/17/2025	42	1057.23
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/18/2025	67	1715.96
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/27/2025	23729	676195.48
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	2063	55465.41

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 for Phreesia (PHR) report?

The form reports a proposed sale of 78 restricted common shares (acquired 08/15/2025 via vesting) with an aggregate market value of $2,274.13, and lists several insider sales during June–July 2025.

Who is the broker for the proposed sale?

The proposed sale lists Fidelity Brokerage Services LLC at the address provided, with the trade planned on the NYSE on approximately 08/18/2025.

What recent insider sales are disclosed in the filing?

Jessica Weiss sold 42 shares (06/17/2025) and 67 shares (06/18/2025). David Linetsky sold 23,729 shares (06/27/2025) and 2,063 shares (07/17/2025), with gross proceeds shown for each.

Was the acquired stock paid as cash or compensation?

The 78 shares to be sold were acquired via restricted stock vesting and the filing lists the nature of payment as compensation.

Does the filing state there is undisclosed material information?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.